Orphalan Announces China NMPA's Approval of Its Trientine Tetrahydrochloride Product for the Treatment of Wilson disease

Orphalan Announces China NMPA's Approval of Its Trientine Tetrahydrochloride Product for the Treatment of Wilson disease

Related Keywords

United Kingdom ,China ,Colombia ,Wuhan ,Hubei ,Switzerland ,Paris ,France General ,France ,United States ,Saudi Arabia ,Yan Qin ,Sukaina Virji ,Tongxin Wilson ,Naseem Amin ,Davide Salvi ,Tracy Cheung ,China National Medical Products Administration ,Linkedin ,National Medical Products Administration ,Chief Executive Officer ,Wuhan Tongxin ,Orphalan Nmpa ,Trientine Tetrahydrochloride ,Reatment Of Wilson Disease ,